Skip to search formSkip to main contentSkip to account menu

eugenosedin B

Known as: eugenosedin-B 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PiperazinesStyrenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Eugenosedin‐A prevents high‐fat diet increased adhesion molecules through inhibition of MAPK‐ and p65‐mediated NF‐κB pathway in rat model
Previous studies have shown eugenosedin‐A, a 5‐HT1B/2A and α1/α2/β1‐adrenergic blocker, is able to decrease cholesterol levels… 
2011
2011
Suppression of inflammatory response and endothelial nitric oxide synthase downregulation in hyperlipidaemic C57BL/6J mice by eugenosedin‐A
Objectives  Eugenosedin‐A has been found to ameliorate high‐fat diet (HFD)‐induced hyperglycaemia and hyperlipidaemia in C57BL/6J… 
2008
2008
Hypotensive and Antiaggregative Effects of Eugenosedin-B With Serotonin and α/β-Adrenoceptor Antagonistic Activities in Rats and Human Platelets
Eugenosedin-B is able to block serotonin (5-HT) and α/β receptors and to inhibit platelet aggregation. In Wistar rats… 
2007
2007
Eugenosedin‐A amelioration of lipopolysaccharide‐induced up‐regulation of p38 MAPK, inducible nitric oxide synthase and cyclooxygenase‐2
In this study, we investigate the protective effects of eugenosedin‐A on p38 mitogen‐activated protein kinase (MAPK… 
2005
2005
Eugenosedin-A 調控大鼠基底動脈平滑肌細胞之鉀離子通道研究
In our previous study, Eugenosedin-A was suggested to possess ??1/??2, ??1 and 5-HT1B/5-HT2A receptor-blocking activities. It not… 
2004
2004
Hypotensive Effects of Eugenosedin-A with Serotonin, Alpha- and Beta-Adrenoceptor Antagonistic Activities in Spontaneously Hypertensive and Normotensive Rats
Eugenosedin-A is a newly synthesized compound with special serotonergic, α- and β<sub>1</sub>-adrenergic blocking actions… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)